← Back to news
ResearchBIORXIVFriday, April 17, 2026 · April 17, 2026

Preprint: OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discovery

WHY IT MATTERS

This AI tool could help researchers discover new treatments and understand rare diseases more quickly by automating time-consuming research tasks, potentially leading to faster development of therapies for patients with rare conditions.

Scientists created OpenScientist, a new artificial intelligence tool that can help researchers discover medical breakthroughs faster. This AI assistant can read through lots of medical information, analyze data, and put together what it learns — tasks that normally take human scientists a long time. The goal is to speed up finding new treatments and understanding diseases better.

OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discovery Authors: Roberts, K. F. et al. Server: medRxiv Category: health informatics Abstract: BackgroundAdvances in medicine depend on analyzing large and complex data sources, but discovery is partly constrained by the limited time and domain expertise of human researchers. Agentic artificial intelligence (agentic AI) can accelerate discovery by automating components of the scientific workflow, including information retrieval, data analysis, and knowledge synthesis. AimOpenScientist, an open-source agentic AI co-scientist, aims to accelerate biomedical discovery by semi-autonomously investigating scientist-defined queries and generating clinically relevant, verifiable scientific insi

Read the original at biorxiv
ai-researchbiomedical-discoverydrug-developmentresearch-toolsscientific-innovation